{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:57:00Z","timestamp":1787021820867,"version":"build-2736575974"},"update-to":[{"DOI":"10.1371\/journal.pntd.0007912","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,1,16]],"date-time":"2020-01-16T00:00:00Z","timestamp":1579132800000}}],"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2020,1,6]],"date-time":"2020-01-06T00:00:00Z","timestamp":1578268800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0007912","type":"journal-article","created":{"date-parts":[[2020,1,6]],"date-time":"2020-01-06T13:33:38Z","timestamp":1578317618000},"page":"e0007912","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["A phase 1 randomized safety, reactogenicity, and immunogenicity study of Typhax: A novel protein capsular matrix vaccine candidate for the prevention of typhoid fever"],"prefix":"10.1371","volume":"14","author":[{"given":"Robert T.","family":"Cartee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Thanawastien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Griffin IV","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Mekalanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Bart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6313-1081","authenticated-orcid":true,"given":"Kevin P.","family":"Killeen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,1,6]]},"reference":[{"issue":"4","key":"pntd.0007912.ref001","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S1473-3099(18)30685-6","article-title":"The global burden of typhoid and paratyphoid fevers: a systematic analysis for the Global Burden of Disease Study 2017","volume":"19","author":"JD Stanaway","year":"2019","journal-title":"The Lancet Infectious Diseases"},{"issue":"10","key":"pntd.0007912.ref002","doi-asserted-by":"crossref","first-page":"e969","DOI":"10.1016\/S2214-109X(17)30328-5","article-title":"Updated estimates of typhoid fever burden in sub-Saharan Africa","volume":"5","author":"J-H Kim","year":"2017","journal-title":"The Lancet Global Health"},{"issue":"5","key":"pntd.0007912.ref003","first-page":"346","article-title":"The global burden of typhoid fever","volume":"82","author":"JA Crump","year":"2004","journal-title":"Bull World Health Organ"},{"issue":"9180","key":"pntd.0007912.ref004","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S0140-6736(98)09001-1","article-title":"Typhoid fever in children aged less than 5 years","volume":"354","author":"A Sinha","year":"1999","journal-title":"The Lancet"},{"issue":"Supplement_2","key":"pntd.0007912.ref005","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1093\/cid\/ciy1124","article-title":"Epidemiology of Typhoid and Paratyphoid: Implications for Vaccine Policy","volume":"68","author":"S Saha","year":"2019","journal-title":"Clinical Infectious Diseases"},{"issue":"Supplement_1","key":"pntd.0007912.ref006","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1093\/clinids\/24.Supplement_1.S106","article-title":"Multidrug-Resistant Salmonella typhi: A Worldwide Epidemic","volume":"24","author":"B Rowe","year":"1997","journal-title":"Clinical Infectious Diseases"},{"issue":"1","key":"pntd.0007912.ref007","doi-asserted-by":"crossref","first-page":"5094","DOI":"10.1038\/s41467-018-07370-z","article-title":"The phylogeography and incidence of multi-drug resistant typhoid fever in sub-Saharan Africa","volume":"9","author":"SE Park","year":"2018","journal-title":"Nature Communications"},{"issue":"1","key":"pntd.0007912.ref008","article-title":"Vaccines for preventing typhoid fever","author":"E Anwar","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"45","key":"pntd.0007912.ref009","doi-asserted-by":"crossref","first-page":"7848","DOI":"10.1016\/j.vaccine.2007.08.027","article-title":"Typhoid fever vaccines: Systematic review and meta-analysis of randomised controlled trials","volume":"25","author":"A Fraser","year":"2007","journal-title":"Vaccine"},{"issue":"5","key":"pntd.0007912.ref010","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001261.pub4","article-title":"Vaccines for preventing typhoid fever","author":"R Milligan","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"pntd.0007912.ref011","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1093\/infdis\/150.3.436","article-title":"Reexamination of the Protective Role of the Capsular Polysaccharide (Vi antigen) of Salmonella typhi","volume":"150","author":"JD Robbins","year":"1984","journal-title":"The Journal of Infectious Diseases"},{"issue":"3","key":"pntd.0007912.ref012","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/cid\/civ295","article-title":"Safety and Immunogenicity of a Vi Polysaccharide\u2013Tetanus Toxoid Conjugate Vaccine (Typbar-TCV) in Healthy Infants, Children, and Adults in Typhoid Endemic Areas: A Multicenter, 2-Cohort, Open-Label, Double-Blind, Randomized Controlled Phase 3 Study","volume":"61","author":"VK Mohan","year":"2015","journal-title":"Clinical Infectious Diseases"},{"issue":"2","key":"pntd.0007912.ref013","first-page":"1","article-title":"Safety and Immunogenicity of Salmonella Typhi Vi conjugate vaccine (Peda Typh) in children up to five years","volume":"3","author":"B Chinnasami","year":"2013","journal-title":"International Journal of Scientific Research Publications"},{"issue":"Supplement_1","key":"pntd.0007912.ref014","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1093\/cid\/ciy884","article-title":"Overview of the Typhoid Conjugate Vaccine Pipeline: Current Status and Future Plans","volume":"68","author":"S Sahastrabuddhe","year":"2019","journal-title":"Clinical Infectious Diseases"},{"issue":"11","key":"pntd.0007912.ref015","doi-asserted-by":"crossref","first-page":"5806","DOI":"10.1128\/IAI.67.11.5806-5810.1999","article-title":"Safety and immunogenicity of Vi conjugate vaccines for typhoid fever in adults, teenagers, and 2- to 4-year-old children in Vietnam","volume":"67","author":"Z Kossaczka","year":"1999","journal-title":"Infect Immun"},{"issue":"10","key":"pntd.0007912.ref016","doi-asserted-by":"crossref","first-page":"4440","DOI":"10.1128\/IAI.62.10.4440-4444.1994","article-title":"Laboratory and preliminary clinical characterization of Vi capsular polysaccharide-protein conjugate vaccines","volume":"62","author":"SC Szu","year":"1994","journal-title":"Infection and Immunity"},{"issue":"5","key":"pntd.0007912.ref017","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1128\/CVI.00532-10","article-title":"The Vi Conjugate Typhoid Vaccine Is Safe, Elicits Protective Levels of IgG Anti-Vi, and Is Compatible with Routine Infant Vaccines","volume":"18","author":"VD Thiem","year":"2011","journal-title":"Clinical and Vaccine Immunology"},{"issue":"11","key":"pntd.0007912.ref018","doi-asserted-by":"crossref","first-page":"6586","DOI":"10.1128\/IAI.72.11.6586-6588.2004","article-title":"Effect of Dosage on Immunogenicity of a Vi Conjugate Vaccine Injected Twice into 2- to 5-Year-Old Vietnamese Children","volume":"72","author":"DG Canh","year":"2004","journal-title":"Infection and Immunity"},{"issue":"10","key":"pntd.0007912.ref019","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1093\/nar\/12.10.4063","article-title":"The amino-acid sequence of two non-toxic mutants of diphtheria toxin: CRM45 and CRM197","volume":"12","author":"G Giannini","year":"1984","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"pntd.0007912.ref020","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.4161\/hv.26109","article-title":"Protein carriers of conjugate vaccines: characteristics, development, and clinical trials","volume":"9","author":"ME Pichichero","year":"2013","journal-title":"Hum Vaccin Immunother"},{"issue":"9","key":"pntd.0007912.ref021","doi-asserted-by":"crossref","first-page":"e25398","DOI":"10.1371\/journal.pone.0025398","article-title":"Safety, Immunogenicity and Dose Ranging of a New Vi-CRM197 Conjugate Vaccine against Typhoid Fever: Randomized Clinical Testing in Healthy Adults","volume":"6","author":"P van Damme","year":"2011","journal-title":"PLOS ONE"},{"issue":"26","key":"pntd.0007912.ref022","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1016\/j.vaccine.2018.05.038","article-title":"Safety and immunogenicity of a Vi-DT typhoid conjugate vaccine: Phase I trial in Healthy Filipino adults and children","volume":"36","author":"MR Capeding","year":"2018","journal-title":"Vaccine"},{"issue":"10","key":"pntd.0007912.ref023","doi-asserted-by":"crossref","first-page":"E1143","DOI":"10.1073\/pnas.1425005112","article-title":"Conjugate-like immunogens produced as protein capsular matrix vaccines","volume":"112","author":"A Thanawastien","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"pntd.0007912.ref024","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1080\/21645515.2019.1599674","article-title":"In vitro characterization and preclinical immunogenicity of Typhax, a typhoid fever protein capsular matrix vaccine candidate","volume":"15","author":"TJt Griffin","year":"2019","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"pntd.0007912.ref025","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/pds.2630030105","article-title":"The medical dictionary for drug regulatory affairs (MEDDRA) project","volume":"3","author":"KL Wood","year":"1994","journal-title":"Pharmacoepidemiology and Drug Safety"},{"issue":"1","key":"pntd.0007912.ref026","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0022-1759(98)00170-7","article-title":"A statistically defined endpoint titer determination method for immunoassays","volume":"221","author":"A Frey","year":"1998","journal-title":"Journal of Immunological Methods"},{"issue":"4","key":"pntd.0007912.ref027","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.vaccine.2010.11.022","article-title":"Vi-CRM 197 as a new conjugate vaccine against Salmonella Typhi","volume":"29","author":"F Micoli","year":"2011","journal-title":"Vaccine"},{"issue":"10111","key":"pntd.0007912.ref028","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1016\/S0140-6736(17)32149-9","article-title":"Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial","volume":"390","author":"C Jin","year":"2017","journal-title":"The Lancet"},{"issue":"18","key":"pntd.0007912.ref029","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1056\/NEJM198710293171801","article-title":"Prevention of Typhoid Fever in Nepal with the VI Capsular Polysaccharide of Salmonella Typhi","volume":"317","author":"IL Acharya","year":"1987","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"pntd.0007912.ref030","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0264-410X(94)90194-5","article-title":"Clinical and serological responses following primary and booster immunization with Salmonella typhi Vi capsular polysaccharide vaccines","volume":"12","author":"WA Keitel","year":"1994","journal-title":"Vaccine"},{"issue":"3","key":"pntd.0007912.ref031","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1093\/femsre\/fuy011","article-title":"Potential targets for next generation antimicrobial glycoconjugate vaccines","volume":"42","author":"F Micoli","year":"2018","journal-title":"FEMS Microbiology Reviews"},{"issue":"3","key":"pntd.0007912.ref032","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1093\/infdis\/152.3.634","article-title":"Capsular Antigens Noncovalently or Covalently Associated with Protein as Vaccines to Haemophilus influenzae Type b: Comparison in Two-Year-Old Children","volume":"152","author":"P Anderson","year":"1985","journal-title":"The Journal of Infectious Diseases"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0007912","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,1,16]],"date-time":"2020-01-16T00:00:00Z","timestamp":1579132800000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0007912","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T15:49:35Z","timestamp":1695570575000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0007912"}},"subtitle":[],"editor":[{"given":"Edward T.","family":"Ryan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,1,6]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,1,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0007912","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,6]]}}}